Hanna John Walter JR sold $425K of CDNA
Hanna John Walter JR (President and CEO) sold 17,683 shares of CareDx, Inc. (CDNA) at $24.03 ($0.42M total) on 2026-06-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the CEO’s open-market sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may note the insider sale for sentiment, but the 10b5-1 designation reduces the likelihood of a fundamental repricing catalyst.
What to watch
10b5-1 plans often lead to predictable selling schedules; without additional context (e.g., multiple consecutive sales, changes in plan size), the signal is weak.
Background
The article is a SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA).
Ticker impact
CareDx CEO Hanna John Walter Jr sold 17,683 shares at $24.0274 in an open-market transaction filed as a Form 4.
Likely limited near-term impact; any effect is more sentiment-driven than fundamental.
The filing is a disclosed insider sale (not a buy), but it is explicitly under a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
No clear sector read-through from a single CEO 10b5-1 sale.
None.
None.
Counterpoint
The sale may be purely planned liquidity, so it should not be treated as a bearish signal about CareDx fundamentals.
Key entities
- issuerCareDx, Inc.
Company whose CEO insider sale is disclosed in the Form 4.
- insiderHanna John Walter Jr
President and CEO and reporting person who sold shares.
